Department of Medicine, Division of Critical Care Medicine, MemorialCare - Long Beach Medical Center, Long Beach, California, USA.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California Irvine, Irvine, California, USA.
BMJ Open Qual. 2021 Feb;10(1). doi: 10.1136/bmjoq-2020-001097.
The surge in clinical demand, shortage in personal protective equipment and high-exposure risk for healthcare workers during the COVID-19 pandemic has challenged hospital common practices and forced a reassessment of care delivery models. Code blue teams are highly specialised units that partake in life-saving situations that can jeopardise the safety of team members. There is a paucity of guidance in regards to proper infection control measures to protect the responders.This study describes a methodical approach to assessing vulnerabilities to transmission of SARS-CoV-2 within existing code blue practices, modalities to limit the number of code blue team responders and modifications to the protocol at a large community teaching hospital. The effort undertaken faced challenges due to the nature of the pandemic and the increased demand on healthcare workers. Quality improvement methods facilitated our protocol design and implementation. To this date, there has been no identified COVID-19 disease in any protected code blue (PCB) team members. We recommend that similar practices be considered and adopted widely and practised periodically.
在 COVID-19 大流行期间，临床需求的激增、个人防护设备的短缺以及医护人员面临的高暴露风险，挑战了医院的常规做法，并迫使人们重新评估护理提供模式。 蓝色代码团队是专门从事可能危及团队成员安全的救生情况的高度专业化单位。 关于保护响应者的适当感染控制措施，几乎没有指导。 本研究描述了一种评估 SARS-CoV-2 在现有蓝色代码实践中传播的脆弱性的系统方法、限制蓝色代码团队响应者数量的方法以及在大型社区教学医院修改方案的方法。 由于大流行的性质和医护人员需求的增加，这项工作面临挑战。 质量改进方法促进了我们的方案设计和实施。 迄今为止，任何受保护的蓝色代码 (PCB) 团队成员都没有被发现 COVID-19 疾病。 我们建议广泛考虑并定期采用类似的做法。
